Fig. 4From: Concomitant Sjögren’s disease as a biomarker for treatment effectiveness in rheumatoid arthritis - results from the Swiss clinical quality management cohortDAS28-CRP score at baseline and 1 year follow-up visit (response tolerance remission analysis). The distributions of DAS28-CRP values per group and timepoint are displayed as violin plots (density from lowest to highest value, median indicated by a horizontal line). A, Comparison of DAS28-CRP values between rheumatoid arthritis patients with and without concomitant Sjögren’s disease. B, Comparison of DAS28-CRP values between different treatment modalities within the overlap group. Grey: in remission (DAS28 < 2.6). BL, baseline; CRP, C-reactive protein; DAS28, Disease Activity Score-28; FU, follow-up; JAKi, Janus kinase-inhibitor; OMA, other modes of action; TNFi, Tumour necrosis factor-inhibitorBack to article page